Coming from this article (HN comments):

https://news.cornell.edu/stories/2025/12/ozempic-changing-foods-americans-buy

Ozempic is changing the foods Americans buy

Within six months of starting a GLP-1 medication, households reduce grocery spending by an average of 5.3%. Among higher-income households, the drop is even steeper, at more than 8%. Spending at fast-food restaurants, coffee shops and other limited-service eateries falls by about 8%.

That seems huge to me. There’s lots of memes about bad food practices in the US and there’s a lot of truth to it. In 10 years, will there be a stereotype of Americans as skinny people that don’t eat much?

I don’t have a link but I’ve seen that companies are pushing back on this, like researching how to make drinks that counteract GLP-1 drugs. Will Big Pharma or Big Sugar win out?

Image source, semaglutide molecule

  • Brkdncr@lemmy.world
    link
    fedilink
    English
    arrow-up
    7
    ·
    2 months ago

    It may get cheaper. There’s pills on the way that reduces the costs a lot. If those cost savings make their way to the patient then its cost may offset the additional food and healthcare costs of being overweight.

    But pharma rarely reduces costs for the patient. What will likely happen is the pill form will stay just below the cost of the injectable until it’s valid as a generic. Then pharma will do some shenanigans to further delay it from going generic such as convert it an OTC drug in order to keep costs high.

    • SaveTheTuaHawk@lemmy.ca
      link
      fedilink
      English
      arrow-up
      3
      ·
      2 months ago

      There’s pills on the way that reduces the costs a lot

      in Canada, because the dumb dumbs at Novo forgot to renew their patent.